Rapid decrease of bioequivalently-recognized medicines shows pharmaceutical companies’ hesitation over generic development
Medicines which have been newly recognized in bioequivalence test this year were 481 products, the number was decreased by almost a half compared to the last year’s same time of period.
According to the Ministry of Food and Drug Safety(MFDS), there were total 11,139 medicines approved with bioeq...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
